159 related articles for article (PubMed ID: 36770719)
1. Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues.
Cirri D; Geri A; Massai L; Mannelli M; Gamberi T; Magherini F; Becatti M; Gabbiani C; Pratesi A; Messori L
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770719
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety.
Ronga L; Tolbatov I; Giorgi E; Pisarek P; Enjalbal C; Marrone A; Tesauro D; Lobinski R; Marzo T; Cirri D; Pratesi A
Inorg Chem; 2023 Jul; 62(26):10389-10396. PubMed ID: 37342994
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties.
Landini I; Massai L; Cirri D; Gamberi T; Paoli P; Messori L; Mini E; Nobili S
J Inorg Biochem; 2020 Jul; 208():111079. PubMed ID: 32497830
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent.
Cirri D; Massai L; Giacomelli C; Trincavelli ML; Guerri A; Gabbiani C; Messori L; Pratesi A
Dalton Trans; 2022 Sep; 51(35):13527-13539. PubMed ID: 36000524
[TBL] [Abstract][Full Text] [Related]
5. A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt
Chiaverini L; Baglini E; Mannelli M; Poggetti V; Da Settimo F; Taliani S; Gamberi T; Barresi E; La Mendola D; Marzo T
Biometals; 2023 Oct; 36(5):961-968. PubMed ID: 36869967
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative Properties of a Few Auranofin-Related Gold(I) and Silver(I) Complexes in Leukemia Cells and their Interferences with the Ubiquitin Proteasome System.
Cirri D; Schirmeister T; Seo EJ; Efferth T; Massai L; Messori L; Micale N
Molecules; 2020 Sep; 25(19):. PubMed ID: 32998355
[TBL] [Abstract][Full Text] [Related]
7. Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin.
Cirri D; Fabbrini MG; Massai L; Pillozzi S; Guerri A; Menconi A; Messori L; Marzo T; Pratesi A
Biometals; 2019 Dec; 32(6):939-948. PubMed ID: 31686259
[TBL] [Abstract][Full Text] [Related]
8. Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections.
Feng L; Pomel S; Latre de Late P; Taravaud A; Loiseau PM; Maes L; Cho-Ngwa F; Bulman CA; Fischer C; Sakanari JA; Ziniel PD; Williams DL; Davioud-Charvet E
Molecules; 2020 Nov; 25(21):. PubMed ID: 33139647
[TBL] [Abstract][Full Text] [Related]
9. The electrochemical profiles of Auranofin and Aubipy
Kupiec M; Ziółkowski R; Massai L; Messori L; Pawlak K
J Inorg Biochem; 2019 Sep; 198():110714. PubMed ID: 31170580
[TBL] [Abstract][Full Text] [Related]
10. Gold Nanoclusters as Nanoantibiotic Auranofin Analogues.
Ndugire W; Raviranga NGH; Lao J; Ramström O; Yan M
Adv Healthc Mater; 2022 May; 11(9):e2101032. PubMed ID: 34350709
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic auranofin analogues bearing phosphine, arsine and stibine ligands: A study on the possible role of the ligand on the biological activity.
Giorgi E; Mannelli M; Gamberi T; Durante M; Gabbiani C; Cirri D; Pratesi A
J Inorg Biochem; 2024 Feb; 251():112452. PubMed ID: 38070433
[TBL] [Abstract][Full Text] [Related]
12. Protein Metalation by Medicinal Gold Compounds: Identification of the Main Features of the Metalation Process through ESI MS Experiments.
Geri A; Massai L; Messori L
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446857
[TBL] [Abstract][Full Text] [Related]
13. Gold-Based Metal Drugs as Inhibitors of Coronavirus Proteins: The Inhibition of SARS-CoV-2 Main Protease by Auranofin and Its Analogs.
Massai L; Grifagni D; De Santis A; Geri A; Cantini F; Calderone V; Banci L; Messori L
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421689
[TBL] [Abstract][Full Text] [Related]
14. Micelles based on gold-glycopolymer complexes as new chemotherapy drug delivery agents.
Pearson S; Scarano W; Stenzel MH
Chem Commun (Camb); 2012 May; 48(39):4695-7. PubMed ID: 22473015
[TBL] [Abstract][Full Text] [Related]
15. Anticancer Agents: Does a Phosphonium Behave Like a Gold(I) Phosphine Complex? Let a "Smart" Probe Answer!
Ali M; Dondaine L; Adolle A; Sampaio C; Chotard F; Richard P; Denat F; Bettaieb A; Le Gendre P; Laurens V; Goze C; Paul C; Bodio E
J Med Chem; 2015 Jun; 58(11):4521-8. PubMed ID: 25973667
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules.
Galassi R; Luciani L; Wang J; Vincenzetti S; Cui L; Amici A; Pucciarelli S; Marchini C
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053228
[TBL] [Abstract][Full Text] [Related]
17. A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis.
König P; Zhulenko R; Suparman E; Hoffmeister H; Bückreiß N; Ott I; Bendas G
Cancer Chemother Pharmacol; 2023 Jul; 92(1):57-69. PubMed ID: 37272932
[TBL] [Abstract][Full Text] [Related]
18. Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents.
Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C
Inorg Chem; 2014 Mar; 53(5):2396-403. PubMed ID: 24547701
[TBL] [Abstract][Full Text] [Related]
19. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
[TBL] [Abstract][Full Text] [Related]
20. Broad Spectrum Functional Activity of Structurally Related Monoanionic Au(III) Bis(Dithiolene) Complexes.
Le Gal Y; Filatre-Furcate A; Lorcy D; Jeannin O; Roisnel T; Dorcet V; Fontinha D; Francisco D; Prudncio M; Martins M; Soeiro C; Sousa SA; Leitão JH; Morais TS; Bártolo I; Taveira N; Guerreiro JF; Marques F
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
